Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid Phase 2 ClinicalTrials
Hodgkin Disease; Lymphoma Phase 1/Phase 2 ClinicalTrials
Arthritis; Arthritis, Juvenile Phase 2 ClinicalTrials
Schnitzler Syndrome; Syndrome Phase 2 ClinicalTrials
Crohn Disease Phase 1/Phase 2 ClinicalTrials
Myeloproliferative Disorders Phase 2 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell Phase 2 ClinicalTrials
CONTENTS